UnitedHealth Group (UNH) shares fell 2.20% to $415.85 ahead of its second-quarter earnings report scheduled for Thursday pre-market. Analysts anticipate earnings per share (EPS) of $4.85 and total revenue of $110.77 billion, which reflects a minimal year-over-year growth compared to a 12.9% increase during the same quarter last year.
The company's recent performance has been solid, with three consecutive quarters of exceeding EPS expectations. Last quarter, UnitedHealth achieved EPS of $7.23, surpassing the consensus estimate of $6.56. Quarterly revenue also topped expectations, reaching $111.72 billion against a forecast of $109.57 billion.
Market Reactions and Analyst Outlook
As the initial major healthcare provider reporting earnings this cycle, UnitedHealth's results will be closely scrutinized by investors. The focus will be on Medicare Advantage enrollment trends and the performance of the Optum division. Both areas are critical, particularly in light of recent government reimbursement changes that are expected to influence the market dynamics.
Analysts from various firms have adjusted their outlooks prior to the earnings announcement. For example, TD Cowen has maintained a Hold rating but raised its price target to $430. Truist Securities has a Buy rating with a new target of $480, while Keybanc has increased its target to $475, maintaining an Overweight classification. These adjustments indicate a generally positive sentiment regarding the company's potential.
Key Metrics to Watch
- Projected EPS: $4.85
- Projected Revenue: $110.77 billion
- Current Share Price: $415.85
The consensus among analysts stands at a Buy recommendation, with an average price target of $432.63, suggesting upside potential for investors as the earnings release approaches.
This material is for informational purposes only and is not financial advice.
